Navigation Links
Thomson Reuters Cortellis Drives Drug Discovery and Development With Powerful New Web Services
Date:2/28/2012

PHILADELPHIA, and LONDON, Feb. 28, 2012 /PRNewswire/ -- Thomson Reuters announced the availability of Cortellis for Informatics, a new capability that speeds access to critical life sciences research and development information found on its premiere life sciences platform, Thomson Reuters Cortellis.

Cortellis for Informatics uses sophisticated application programming interfaces (APIs) to enhance the research and development process by delivering real-time access to powerful information and tools for biopharmaceutical competitive intelligence, drug pipeline, and drug research and development.

Each API integrates Thomson Reuters data with proprietary content and public information sources into a comprehensive view that is customized to meet the needs of a company, team or individual researcher. With Cortellis for Informatics, data can be shared in a number of ways, including dashboards, custom reports and alerts, and intranet and mobile applications.

"We worked closely with Thomson Reuters during their development and testing phases, and I am delighted to say that the Cortellis APIs exceed my expectations and allow us to take advantage of Thomson Reuters content in the systems that drive our business," said Dr. William Hayes, director of Decision Support at Biogen Idec.

"For life sciences professionals, Cortellis for Informatics is a significant step forward," said Wendy Hamilton, senior vice president at Thomson Reuters. "The advanced options for obtaining information give customers access to our content beyond Cortellis' highly intuitive web portal. Information can now be incorporated directly on the user's preferred systems, customized to their needs, creating additional opportunities for integration across the entire organization."

Cortellis for Informatics streamlines information sharing across all levels of the organization. Instead of using multiple systems to manage workflows, researchers access up-to-the-minute news in the office, in meetings or at the bench. This ability to deploy high-quality Thomson Reuters information across the whole company in real time within internal systems provides greater opportunities for collaboration in the scientific search and discovery process.

Cortellis for Informatics provides web services for investigational drugs, drug targets, ontologies, patents, clinical trials and analytics.

For more information on Cortellis, visit cortellis.thomsonreuters.com.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals.  We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
2. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
3. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
4. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
5. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
6. Thomson Reuters Examines Highly Cited Research in Bioterrorism
7. Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available
8. Brazils Scientific Research On The Rise, Thomson Reuters Study Finds
9. Thomson Reuters Partners With Sagient Research
10. Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook
11. Thomson Reuters Joins the InChI Trust
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
(Date:6/23/2016)... PUNE, India , June 23, 2016 /PRNewswire/ ... culture media market research report to its pharmaceuticals ... company profiles, product details and much more. ... market spread across 151 pages, profiling 15 companies ... now available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/2/2016)... 2, 2016 Perimeter Surveillance & ... Systems, Physical Infrastructure, Support & Other Service  ... offers comprehensive analysis of the global Border ... generate revenues of $17.98 billion in 2016. ... a leader in software and hardware technologies for advanced ...
Breaking Biology News(10 mins):